The CEO As R&D Chief – An Interview With Carl Zeiss’ Michael Kaschke
Given the importance of rapid and persistence technology development in medical devices, why is it that so few medtech CEOs come from R&D? Michael Kaschke, president and CEO of Carl Zeiss, is the exception that proves the rule. Kaschke joined the company in 1992 and began a steady ascent through the management ranks. In an interview, adapted from a recent session in the Innovator’s Workbench series sponsored by the BioDesign Program at Stanford University, Kaschke talks about Zeiss and its strong R&D culture, about how his own background in technology development shapes his approach to decision-making and about the challenges the company has faced in the past and the ones it faces going forward.
You may also be interested in...
In his last interview before becoming CEO of Johnson & Johnson, Alex Gorsky talks about the changes that J&J has made recently in its medical device business and discusses his upcoming promotion to head of all of J&J.
Sue Nabi’s success at L’Oreal, where she headed the firm’s global L’Oreal Paris and Lancome businesses, her skin-care savvy as founder of the luxury, “clean, green and vegan” Orveda, and her experience as a career champion of diversity were major draws for Coty, where she begins as CEO on 1 September.
Chief executive Eric Hobbs talks about the technology needed to accelerate antibody, cell therapy and synthetic biology, and prepare for the next pandemic.